Selected outcomes in 2018

During working and utilization of our large research infrastructure BBMRI.cz were created plenty of unique outcomes. Here we mention some of them:

Azqueta, A., Rundén-Pran, E., Elje, E., Nicolaissen, B., Berg, K.H., Smeringaiova, I., Jirsova, K., Collins, A.R. The comet assay applied to cells of the eye. Mutagenesis 2018;33(1):21-24. doi: 10.1093/mutage/gex025. (IF2017: 2,840)
Brejchova, K., Trosan, P., Studeny, P., Skalicka, P., Utheime, Tp., Bednar, J., Jirsova, K. Characterization and Comparison of Human Limbal Explant Cultures Grown Under Defined and Xeno-Free Conditions. Exp Eye Res 2018;176:20-28. doi: 10.1016/j.exer.2018.06.019. (IF2017: 3,152)
Coates,J., Nenutil, R., Holčáková, J., Nekulová, M., Podhorec, J., Svoboda, M., Vojtěšek, B. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival. Virchows Arch 2018;472(3):351-359. doi: 10.1007/s00428-018-2324-2. (IF2017: 2,936)
Demlova, R., Zdrazilova-Dubska, L., Sterba, J., Stanta, G., Valik, D. Host-dependent variables: the missing link to personalized medicine. Eur J Surg Oncol 2018;44(9):1289-1294. doi: 10.1016/j.ejso.2018.04.014. (IF2017: 3,688)
Hajkova, N., Hojny, J., Nemejcova, K., Dundr, P., Ulrych, J., Jirsova, K., Glezgova, J., Ticha, I. Germline mutation in the TP53 gene in uveal melanoma. Sci Rep 2018;8(1):7618. doi: 10.1038/s41598-018-26040-0. (IF2017: 4,122)
Laco, J., Kovaříková, H., Chmelařová, M., Vošmiková, H., Sieglová, K., Baranová, I., Dundr, P., Němejcová, K., Michálek, J., Šatanková, J., Vošmik, M., Ryška, A. MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study. Virchows Arch 2018;472(5):871-875. doi: 10.1007/s00428-018-2293-5. (IF2017: 2,936)
Pilátová, K., Bencsiková, B., Demlová, R., Valík, D., Zdražilová Dubská, L. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment. Cancer Immunol Immun 2018;67(12):1919-1929. doi: 10.1007/s00262-018-2166-4. (IF2017: 4,225)
Ryska, A., Buiga, R., Fakirova, A., Kern, I., Olszewski, W., Plank, L., Seiwerth, S., Toth, E., Zivka, E., Thallinger, C., Zielinski, C., Brcic, L. Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group. Oncologist 2018;23(12):e152-e158. doi: 10.1634/theoncologist.2018-0008. (IF2017: 5,306; Q1)
Smeringaiova, I., Reinstein Merjava, S., Stranak, Z., Studeny, P., Bednar, J., Jirsova, K. Endothelial Wound Repair of the Organ-Cultured Porcine Corneas. Curr Eye Res 2018;43(7):856-865. doi: 10.1080/02713683.2018.1458883. (IF2017: 3,152)
Truxova, I., Kasikova, L., Hensler, M., Skapa, P., Laco, J., Pecen, L., Belicova, L., Praznovec, I., Halaska, M.J., Brtnicky, T., Salkova, E., Rob, L., Kodet, R., Goc, J., Sautes-Fridman, C., Fridman, W.H., Ryska, A., Galluzzi, L., Spisek, R., Fucikova, J. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J Immunother Cancer 2018;6(1):139. doi: 10.1186/s40425-018-0446-3. (IF2017: 8,374; Q1)